FOR INFORMATION CONTACT:
Lori Gardner, Senior Director
Communications & Marketing
301.984.9496 ext. 226
For Immediate Release: July 27, 2009
Baltimore Surgeon and Leading Melanoma and Breast Cancer Expert to Receive ACCC's Clinical Research Award
Charles M. Balch, MD, FACS, to be honored at ACCC’s Oncology Economics Conference
ROCKVILLE, Md.—Charles M. Balch, MD, FACS, will receive the Association of Community Cancer Centers’ 2009 Clinical Research Award at ACCC’s 26th National Oncology Economics Conference, September 22-25, 2009, in Minneapolis, Minn. He will be honored on September 24 for his extensive research, leadership, and commitment to individuals with cancer. Dr. Balch is professor of surgery and oncology and dermatology and deputy director at the Johns Hopkins Institute for Clinical and Translational Research in Baltimore, Md.
Dr. Balch leads a distinguished career as a clinical and academic surgical oncologist and a leading authority in both melanoma and breast cancer. As revered teacher, astute administrator, and world-renowned speaker, he continues to build networks in the field of clinical trials and outcomes research. Over the past 30 years he has authored more than 600 publications on topics such as, clinical investigations involving the natural history of melanoma, prognostic factors predicting clinical outcomes, standards of surgical treatment, and the conduct and methodology of clinical research and immunology. Dr Balch is generally regarded as one of the leading melanoma experts in the world. He is the editor of “Cutaneous Melanoma,” regarded as the authoritative textbook on melanoma, now in its 5th edition. He is the founding editor-in-chief of the Annals of Surgical Oncology and is chair of the Melanoma Staging Committee of the American Joint Committee on Cancer.
Prior to coming to Johns Hopkins, Dr. Balch held major leadership roles involving clinical research in three comprehensive cancer centers (UAB, M D Anderson, and City of Hope). He has been a principal investigator or co-PI of numerous clinical trials, including 10 phase III trials, most of which were NCI-funded national phase III trials. He has organized or participated in randomized surgical trials that have defined the current standards of melanoma surgery. Dr. Balch’s leadership roles have involved the Society of Surgical Oncology (president), the American Board of Surgery (Board of Directors), the Association of Academic Surgeons (president) and the Commission on Cancer (chair, Board of Directors) and the American Joint Committee on Cancer (Executive Committee).
Dr. Balch has more than 30 years of experience in breast cancer management and research. He has multiple publications with scientific articles and book chapters involving the multidisciplinary and surgical management of breast diseases. His clinical trials leadership in breast cancer in the 1980s and 1990s included the only randomized surgical trial comparing radial vs. modified radical mastectomy, as well as the early development of skin-sparing mastectomy and immediate breast construction; two major advances at the time which contributed to the evolution of breast surgery. He was also one of the early pioneers on developing the sentinel lymph node biopsy in the staging of breast cancer, especially in breast cancer patients who had received pre-operative chemotherapy. Dr Balch was the founding editor of Breast Diseases, which is now in its eighteenth year of publication.
Among the past winners of ACCC’s prestigious annual Outstanding Achievement in Clinical Research Award are David H. Johnson, MD; Lillian M. Nail, PhD, RN, FAAN; Daniel D. Von Hoff, MD, FACP; Saul Rivkin, MD; Henry Lynch, MD; and Vincent DeVita, Jr, MD.